Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-03-22

Clinical Trial Update: Garlic in Hyperlipidemia Caused by HAART [Phase 2]

View source ↗

Summary

This update indicates a Phase 2 trial evaluating garlic for HAART-induced hyperlipidemia in people with HIV has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Garlic (Allium sativum)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: HIV Infections, Hypercholesterolemia | Phase 2 | Status: WITHDRAWN